Emerging research in Dr. Peter Greer's laboratory shows that calpain proteases promote cancer metastasis, which is responsible for most cancer deaths. With funds from a new five year CIHR grant we are exploring calpains as novel therapeutic targets in the treatment of breast and ovarian cancer. This exciting research involves a range of molecular genetic approaches (including CRISPR gene targeting) as well as preclinical models of breast and ovarian cancer.
Students interested in pursuing a MSc or PhD in cancer research are encouraged to contact Dr. Greer at greerp@queensu.ca